Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Sanne A A van Dartel; Jaap Fransen; Wietske Kievit; Marcel Flendrie; Alfons A den Broeder; H Visser; A Hartkamp; Mart A F J van de Laar; Piet L C M van Riel

doi:10.1136/annrheumdis-2012-201338

Article info

Clinical and epidemiological research

Extended report

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Authors

Sanne A A van Dartel Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands PubMed articles Google scholar articles
Jaap Fransen Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands PubMed articles Google scholar articles
Wietske Kievit Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands PubMed articles Google scholar articles
Marcel Flendrie Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands PubMed articles Google scholar articles
Alfons A den Broeder Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands PubMed articles Google scholar articles
H Visser Department of Rheumatology, Rijnstate Hospital, Arnhem, The Netherlands PubMed articles Google scholar articles
A Hartkamp Department of Rheumatology, Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands PubMed articles Google scholar articles
Mart A F J van de Laar Department of Rheumatology, Arthritis Centre Twente, University of Twente and Medisch Spectrum Twente, Enschede, Netherlands PubMed articles Google scholar articles
Piet L C M van Riel Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands PubMed articles Google scholar articles

Correspondence to Dr Jaap Fransen, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Huispost 470, Postbus 9101, Nijmegen 6500 HB, The Netherlands; J.Fransen{at}reuma.umcn.nl

View Full Text

Citation

van Dartel SAA, Fransen J, Kievit W, et al

Annals of the Rheumatic Diseases 2013;72:895-900.

Publication history

Received January 13, 2012
Accepted July 3, 2012
First published August 11, 2012.

Online issue publication

May 26, 2023

Article Versions

Previous version (12 January 2023).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password